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Optimal exercise program length for patients with
claudication
Andrew W. Gardner, PhD,a,b,c Polly S. Montgomery, MS,a,b,c and Donald E. Parker, PhD,d
Oklahoma City, Okla; and Baltimore, Md
Background: This prospective, randomized controlled clinical trial determined whether an optimal exercise program
length exists to efficaciously change claudication onset time (COT) and peak walking time (PWT) in patients with
peripheral artery disease and claudication.
Methods: The study randomized 142 patients to supervised exercise (n 106) or a usual care control group (n 36), with
80 completing the exercise program and 27 completing the control intervention. The exercise program consisted of
intermittent walking to nearly maximal claudication pain 3 days per week. COT and PWT were the primary outcomes
obtained from a treadmill exercise test at baseline and bimonthly during the study.
Results: After exercise, changes in COT (P < .001) and PWT (P < .001) were consistently greater than changes after the
control intervention. In the exercise program, COT and PWT increased from baseline to month 2 (P < .05) and from
months 2 to 4 (P < .05) but did not significantly change from months 4 to 6 (P > .05). When changes were expressed
per mile walked during the first 2 months, middle 2months, and final 2months of exercise, COT and PWT only increased
during the first 2 months (P < .05).
Conclusions: Exercise-mediated gains in COT and PWT occur rapidly within the first 2 months of exercise rehabilitation
and are maintained with further training. The clinical significance is that a relatively short 2-month exercise programmay
be preferred to a longer program to treat claudication because adherence is higher, costs associated with personnel and use
of facilities are lower per patient, and more patients can be trained for a given amount of personnel time and resource
utilization. (J Vasc Surg 2012;55:1346-54.)
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PPeripheral artery disease (PAD) is prevalent in12% of
the United States population aged 65 years1 and is asso-
ciated with elevated rates of death.2,3 Claudication, a com-
mon manifestation of PAD, is prevalent in6% of those in
this age group and leads to ambulatory dysfunction4,5 and
a physically inactive lifestyle.6 Exercise rehabilitation is a
widely recognized conservative approach for the treatment of
claudication because medically supervised programs effica-
ciously increase claudication onset time (COT) and peak
walking time (PWT).1,7 Consequently, supervised exercise
rehabilitation has been given a class I recommendation by the
American College of Cardiology and the American Heart
Association, indicating general agreement for effectiveness of
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1346reatment, supported by level A evidence derived frommulti-
le randomized controlled trials and meta-analyses.1
Although treatment of claudication with exercise reha-
ilitation is well documented, the importance of various
lements that comprise the exercise prescription remains
ess clear. A recent meta-analysis concluded that an optimal
xercise regimen, such as the optimal intensity and duration
f exercise, could not be determined.8 We previously re-
orted in a randomized trial that increases in COT and
WT after 6 months of exercise were not different between
hose who trained at 40% and 80% of maximal intensity,
rovided that they completed a similar volume of exercise.9
he optimal length of an exercise program to increase COT
nd PWT is not clear, which has major implications related
o the efforts of patients and staff and use of resources at
edical and research facilities. Determining the shortest
ength of exercise to elicit the majority of improvements in
OT and PWT is a necessary step to optimally treat more
atients with less expense and fewer resources.
This prospective, randomized controlled clinical trial
etermined whether an optimal exercise program length
xists to efficaciously change COT and PWT in patients
ith PAD and claudication. We hypothesized that COT and
WT improve most rapidly during the early phase of a
-month exercise rehabilitation program and less so by the
nd.
ETHODS
atients
The procedures used in this study were approved by the
nstitutional Review Board at the University of Maryland
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Volume 55, Number 5 Gardner et al 1347and by the Research and Development Committee at the
Maryland Veterans Affairs Health Care System in Baltimore
(MVAHCS). Written informed consent was obtained from
each patient before the investigation.
Patient recruitment. Patients were evaluated in the
Geriatrics, Research, Education and Clinical Center,
MVAHCS, at Baltimore. Patients were recruited from the
vascular clinic in the Baltimore MVAHCS and from news-
paper and radio advertisements for possible enrollment.
The study was designed to assess the efficacy of exercise at
intermediate intervals during a 6-month exercise program.
Statistical power analyses were performed on the pri-
mary outcome measures of COT and PWT. Exercise and
control group sample sizes of 75 and 25, respectively,
achieved 80% power to detect a group difference in change
scores from a baseline of 120 seconds for COT and 150
seconds for PWT, using a two-sided two-sample t-test and
a significance level of   0.05. To allow for a dropout rate
of 30%, we targeted randomizing at least 100 and 35
patients to the groups. A consecutive series of 241 individ-
uals was evaluated for study eligibility.
Medical screening through history, physical exam-
ination, and anthropometry. Demographic information,
height, weight, body mass index (BMI), waist and hip
circumferences,10 cardiovascular risk factors, comorbid
conditions, claudication history, blood samples, and a list of
current medications were obtained from a medical history
and physical examination at the beginning of the study. The
medication regimen of each patient was held constant
during the study.
Inclusion and exclusion criteria. Patients with clau-
dication secondary to vascular insufficiency were included if
theymet the following criteria: (1) a history of claudication,
defined as reporting leg pain upon exertion, (2) ambulation
during a graded treadmill test limited by claudication,4 and
(3) an ankle-brachial index (ABI) 0.90 at rest11 or a 20%
decrease in ABI after exercise.7
Patients were excluded from the study for the following
conditions: (1) absence of PAD (ABI 0.90 at rest and
20% decrease after exercise), 17 patients7,11; (2) asymp-
tomatic PAD12 determined from the medical history and
verified during the graded treadmill test, two patients; (3)
rest pain PAD, five patients; (4) inability to obtain an ABI
measure due to noncompressible vessels (ie, systolic blood
pressure could be heard as the sphygmomanometer was
inflated to themaximal value of 300mmHg), four patients;
(5) use of cilostazol and pentoxifylline 3 months of the
investigation, four patients; lower extremity revasculariza-
tion 3 months before the investigation, six patients; (6)
exercise tolerance limited by any disease process other than
PAD, such as angina, dyspnea, or evidence of myocardial
ischemia or rhythm changes from a 12-lead electrocardio-
gram, 25 patients; (7) uncontrolled hypertension, uncon-
trolled diabetes, active cancer, renal insufficiency, or abnor-
mal liver function, 15 patients; and (8) noncompliance with
baseline testing, 21 patients.
Randomization and flow of patients. Patients were
randomized to supervised exercise (n  106) or to a usual rare control group (n  36) in a 3:1 ratio using a random
umber program with blocking to ensure that the 3:1
andomization scheme was maintained throughout study
llocation. Study personnel were allowed access to the alloca-
ion list only after patient eligibility was determined and base-
ine data were completed. Flow of patients in the study is
hown in Fig 1.
ntervention and control groups
Exercise rehabilitation program. The exercise reha-
ilitation program was designed to elicit increases in COT
nd PWT according to our previous studies.13-15 This
rogram consisted of 6 months of supervised, intermittent
readmill walking to near-maximal claudication pain 3 days
er week. Walking duration and intensity of the sessions
ere progressively increased during the program. Walking
uration began at 15 minutes for the first month of the
rogram and increased by 5 minutes per month until 40
inutes of walking was accomplished by the sixth month of
ehabilitation. Walking intensity began at an initial grade of
0% of the final workload attained during the baseline
raded treadmill test and was increased by 10% every 6
eeks up to 80% during the final 6 weeks of the exercise
rogram. During each exercise session, patients walked at
pproximately 2 mph until their claudication pain reached a
evel of 3 on a 0 to 4 pain scale (0  no pain, 1  onset of
ain, 2  moderate pain, 3  intense pain, and 4 
aximal pain),13 after which they rested until claudication
ain completely resolved. This pattern of intermittent walk-
ng and rest continued until the prescribed number of
inutes of walking was accomplished. Five minutes of
ycling on a stationary bicycle ergometer served as a
arm-up and cool-down during each exercise session. The
rogram was supervised by exercise physiologists and
urses.
To quantify volume of exercise performed in the super-
ised exercise program, metabolic equivalent (MET)-
inutes were calculated as the product of exercise intensity,
xpressed as METs and exercise duration expressed in
inutes.16 Calculation of MET-minutes is clinically useful
o summarize the total amount of exercise performed dur-
ng training because it provides a summative score for
xercise duration, intensity, and frequency. In this manner,
he amount of exercise performed can be better compared
ith other studies. The metabolic intensity of each exercise
raining session was determined from objectively measured
xygen uptake during the most recent graded treadmill test
f each patient. Oxygen uptake corresponding to the train-
ng grade was then divided by 3.5 to convert to METs, and
his value was multiplied by the duration of each supervised
xercise session to yield a MET-minute value. Patients in
he supervised program were not given advice or instruc-
ions to perform additional exercise away from our research
enter.
No exercise, usual care control group. Patients ran-
omized to this group were encouraged to walk more on
heir own but did not receive specific recommendations
egarding an exercise program during the study. This ap-
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May 20121348 Gardner et alproach is similar to advice typically given by clinicians
during routine follow-up vascular appointments. No other
risk factor management, lifestyle modification, or educa-
tional programming interventions were provided to pa-
tients in either group. The measurements listed in the next
section were obtained at baseline and at 2, 4, and 6 months
during the study.
Primary outcome measurements
COT and PWT obtained during the graded tread-
mill test. Patients performed a progressive, graded tread-
mill protocol (walking speed of 2 mph beginning at 0%
grade, which increased by 2% every 2 minutes) to deter-
Fig 1. Consolidated Standards of Reporting Trials (CO
trial.mine study eligibility and to obtain outcome measures belated to exercise performance.4 The COT, defined as the
alking time at which the patients first experienced pain,
nd the PWT, defined as the walking time at which ambu-
ation could not continue due to maximal pain, were re-
orded to quantify the severity of claudication. Peak oxygen
ptake was measured by oxygen uptake obtained during
he peak exercise workload with a Medical Graphics
O2000 metabolic system (Medical Graphics Inc, St Paul,
inn). The test–retest intraclass reliability coefficient using
hese procedures is R  0.89 (95% confidence interval
CI], 0.86-0.91) for COT,4R 0.93 (95% CI, 0.91-0.94)
or PWT,4 and R  0.88 (95% CI, 0.83-0.92) for peak
xygen uptake.17 The final grade attained during this test at
RT) flow diagram of patients through each stage of theNSOaseline was used to calculate the training intensity of the
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Volume 55, Number 5 Gardner et al 1349exercise group during the first 2months, and the final grade
attained during this test at months 2 and 4 was used to
determine the intensity during the subsequent 4 months.
Secondary outcome measures
ABI and ischemic window. As previously described,
ABI measures were obtained from the more severely dis-
eased lower extremity before and at 1, 3, 5, and 7 minutes
after the treadmill test.4 The reduction in ankle systolic
blood pressure after treadmill exercise from resting baseline
was quantified by calculating the area under the curve,
referred to as the ischemic window.18 Because the ischemic
window is a function of PAD severity and the amount of
exercise performed, the ischemic window was normalized
per meter walked.
Six-minute walk test. A trained technician adminis-
tered the over-ground, 6-minute walk test in which two
cones were placed 100 feet apart in a marked corridor.19
Patients were instructed to walk as many laps as possible
around the cones. During the test, patients indicated if and
when they experienced the onset of claudication pain. The
pain-free and total distances walked during the test were
recorded. The test–retest intraclass reliability coefficient is
R  0.75 (95% CI, 0.70-0.81) for the distance to onset of
claudication pain and R  0.94 (95% CI, 0.92-0.95) for
the total 6-minute walking distance.19
Walking Impairment Questionnaire. Self-reported
ambulatory ability was assessed using the validatedWalking
Impairment Questionnaire (WIQ) for PAD patients that
assesses the ability to walk at various speeds and distances
and to climb stairs.20
Daily physical activity. Physical activity level was
monitored over 2 consecutive weekdays by a Caltrac accel-
erometer (Muscle Dynamics, Torrance, Calif) attached to
the belt of each patient.21 The accelerometer assessed daily
physical movements by converting vertical accelerations of
the body into caloric expenditure during the 48-hour mon-
itoring period. The accelerometer measure of physical ac-
tivity has a test–retest intraclass reliability coefficient ofR
0.84 (95%CI, 0.77-0.90)22 and provides a valid estimate of
daily physical activity assessed by the gold standard tech-
nique of doubly labeled water.21
Calf blood flow. Calf blood flow was obtained under
resting, reactive hyperemic, and maximal hyperemic condi-
tions in the more severely diseased leg using venous occlu-
sion mercury strain-gauge plethysmography.23 The test–
retest intraclass reliability coefficient is R  0.86 (95% CI,
0.83-0.88) for calf blood flow.23
Statistical analyses
Independent t-test was used for comparison of baseline
means and a one degree of freedom 2 test for proportions
of two groups. Subsequent comparisons were performed as
intent-to-treat analyses by first imputing missing values
before proceeding. A group-by-time analysis of variance
with repeated measure on the time factor was the initial
procedure for comparison of means. The time simple effect
within each group with Tukey-Kramer multiple-comparison cest was used for comparisons among the means at each
ime and was performed for all variables for which a signif-
cant interaction was observed. For each 2-month interval
fter baseline, the regression of miles walked on change in
WT from the preceding test was used to examine the
elationship of these two variables in the exercise group.
his relationship was further examined by computing the
atio of the change for each individual to the miles walked
ince the preceding test and graphically displaying the
eans for each interval. A similar examination was made for
OT. All analyses and imputation procedures were per-
ormed using NCSS software (NCSS, Kaysville, Utah).
tatistical significance was set at P  .05.
ESULTS
Randomization resulted in similar baseline clinical
haracteristics between groups, except that the exercise
roup weighed less than the control group (P  .023;
able I). A total of 107 patients completed the study,
hereas 35 did not (Fig 1). Of the 35 patients who did not
omplete, 26 were from the exercise group and nine were
ontrols. The primary reasons for discontinuing were lack
f interest, serious adverse events, and lack of transporta-
ion. The serious adverse events, which were exclusionary
or study continuation, consisted of three patients with
erebral vascular accidents, two with uncontrolled hyper-
ension, and one patient each with myocardial infarction,
oronary artery bypass graft, below-knee amputation, deep
ein thrombosis, and a broken ankle. Three additional
erious adverse events occurred that did not result in study
xclusion, consisting of one patient each with hospitaliza-
ion for pneumonia, hospitalization for hernia surgery, and
back injury.
Adherence to the exercise program. Adherence to
xercise was 74%  33% during the entire study: patients
ompleted an average of 53 24 sessions of a possible 72
cheduled (Table II). Exercise adherence progressively de-
able I. Baseline clinical characteristics
ariablesa
Control
group
(n  36)
Exercise
group
(n  106) P
ge, years 68 (8) 68 (8) .651
eight, kg 87.1 (16.5) 80.6 (14.2) .023
ody mass index, kg/m2 29.5 (4.6) 27.9 (4.7) .077
nkle-brachial index 0.70 (0.18) 0.64 (0.21) .124
hite race 69 53 .082
ale sex 83 86 .713
urrent smoking 39 46 .444
iabetes 20 26 .458
ypertension 64 64 .978
yslipidemia 60 58 .829
besity 33 25 .361
etabolic syndrome 54 56 .878
rior revascularization 17 13 .509
Values are means (standard deviations) or percentage of patients meeting
he characteristic.lined from the first 2 months (86%  25%) to the final 2
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duration of 1370 704minutes, the total walking distance
was 46.8  25.5 miles, and the total exercise volume was
4815  2705 MET-minutes. A substantial training effect
was evident: progressive increases in walking grade during
the program did not elicit increases in heart rate and blood
pressure during exercise training sessions. Furthermore,
walking became more economical during the training ses-
sions: the estimated oxygen uptake remained relatively
constant even though the treadmill grade was progressively
increased.
Primary outcome measures. COT and PWT during
Table II. Measures from the exercise group during their e
Variablesa
1 and 2
(n  106)
Exercise sessions completed
Number 21 (6)
Percentage 86 (25)
Exercise duration, min/session 17 (1)
Total exercise time, min 354 (111)
Total distance walked, milesb 12.0 (4.3)
Estimated oxygen uptake, mL/kg/min 12.3 (2.7)
Exercise intensity, MET/min 3.5 (0.8)
Total exercise volume, MET-minc 1239 (491)
Walking speed, mph 2.0 (0.3)
Walking grade, % 3.7 (2.6)
Heart rate, beats/min 103 (13)
Blood pressure, mm Hg
Systolic 167 (17)
Diastolic 83 (8)
MET, Metabolic equivalents.
aValues are means (standard deviation).
bMileage determined by multiplying walking speed (expressed in mph) and
cMET-minutes of exercise determined by multiplying exercise intensity (exp
Table III. Treadmill test exercise performance measures o
exercise group (n  106)
Variablesa Baseline Month 2
Claudication onset time, sec
Control group 146 (112) 225 (136)b
Exercise group 189 (142) 333 (188)b
Peak walking time, sec
Control group 386 (226) 469 (155)
Exercise group 431 (243) 651 (267)b
Peak oxygen uptake, mL/kg/min
Control group 14.2 (3.3) 14.9 (4.6)
Exercise group 13.8 (3.4) 14.4 (3.6)
Ischemic window, AUC
Control group 0.75 (0.82) 0.64 (0.54)
Exercise group 0.81 (0.66) 0.39 (0.47)
ANOVA, Analysis of variance; AUC, area under the curve; GE, group effect
effect.
aValues are means (standard deviation).
bChange from baseline (P  .05).
cChange from month 2 (P  .05).the graded treadmill test increased in the exercise group mP  .001) and in the control group (P  .001), but
hanges were consistently greater in exercise group (inter-
ction P .001; Table III). COT and PWT in the exercise
roup progressively increased from baseline to month 2
P .05) and from months 2 to 4 (P .05), but there was
o significant change from months 4 to 6 (P .05). When
hange scores in COT and PWT were expressed per mile
ompleted during exercise rehabilitation, the large gains
een during the first 2 months of training dissipated during
he final 4 months (Fig 2). The regression estimates for
inear trend of changes in COT and PWT regressed on
iles walked is reported in Table IV. During the first 2
ise rehabilitation sessions
Months
3 and 4 5 and 6 1 through 6
(n  88) (n  80) (n  106)
17 (9) 15 (10) 53 (24)
73 (39) 63 (42) 74 (33)
26 (2) 36 (3) 24 (5)
467 (256) 549 (374) 1370 (704)
19.5 (6.4) 25.0 (9.0) 46.8 (25.5)
12.2 (2.6) 12.5 (2.6) 12.3 (2.3)
3.5 (0.7) 3.6 (0.7) 3.5 (0.7)
1949 (695) 2595 (1010) 4815 (2705)
2.1 (0.3) 2.1 (0.4) 2.1 (0.4)
5.3 (3.0) 6.4 (3.4) 5.5 (3.4)
103 (13) 103 (13) 103 (14)
165 (15) 166 (15) 166 (17)
82 (8) 81 (8) 82 (9)
exercise time.
in METs) and total exercise time.
ients in the usual care control group (n  36) and
Month 4 Month 6
ANOVA P for ITT
GE TE GxT
213 (158)b 218 (159)b .001 .001 .001
382 (210)b,c 411 (232)b,c
436 (236) 446 (308) .001 .001 .001
711 (286)b,c 746 (297)b,c
14.5 (3.3) 14.5 (3.8) NS .01 .001
14.8 (2.9)b 15.4 (3.6)b,c
0.49 (1.53) 0.69 (0.91) NS .001 .001
0.45 (0.35)b 0.40 (0.29)b
group by test interaction; ITT, intent-to-treat;NS, not significant; TE, testxercf pat
b
; GxT,onths of exercise, the regression estimates of change in
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.035) and 17.2 (P  .046), respectively (Table IV). The
changes in COT and PWT during the final 4 months of
exercise were minimal (P  .05) and did not exceed 1.4
seconds per mile walked (Table IV).
Secondary outcomemeasures. The ischemic window
after the treadmill test and peak oxygen uptake both im-
proved in the exercise group (P  .001), which was differ-
ent than changes in the controls (P .001; Table III). For
self-paced exercise performance measurements, pain-free
distance and total distance walked during the 6-minute
walk test increased in the exercise group (P  .001; Table
V), which was different than changes in the controls (P 
.001). WIQ speed score, daily physical activity, and calf
blood flow under resting, reactive hyperemic, and maximal
hyperemic conditions were increased in the exercise group
(P  .001; Table V), which was different than changes in
the controls (P  .001). Although the group by test
interaction was significant for WIQ speed score, the test
main effect was not significant because the increases in the
exercise group were countered by the decreases in the
control group. It should be further noted that the baseline
WIQ measures and other measures of baseline ambulation,
such as COT, PWT, peak oxygen uptake, and 6-minute
walk pain-free distance and total walking distance, were not
different between the exercise and control groups. In fact,
the exercise group had higher baseline values on some
measures than the control group and lower values on
others.
DISCUSSION
Novel findings: Length of exercise program. The
primary novel finding of this investigation is that exercise-
mediated gains in COT and PWT occur rapidly within the
first 2 months of exercise rehabilitation and are maintained
with further training. This is quite remarkable, given that
Claudication
Onset Time
Peak Walking
Time
C
ha
ng
es
 p
er
 M
ile
s 
W
al
ke
d
(s
ec
/m
ile
)
Months in Exercise Program
-5
0
5
10
15
20
0 to 2 2 to 4 4 to 6
Fig 2. Changes in claudication onset time (COT) and peak walk-
ing time (PWT) per mile walked during different stages of an
exercise rehabilitation program.only a small percentage of the total mileage walked (26%) pnd the total MET-minutes of exercise completed (26%)
ere accomplished during the first 2 months. This finding
as major implications for patients, exercise program per-
onnel, and utilization of resources and facilities.
From the patient’s viewpoint, claudication severity can
e improved with relatively little effort by walking an
verage of 1.5 miles per week for 2 months. These realistic
hort-term targets may make an exercise program less
aunting for many patients and may be a motivating factor.
rom the viewpoint of the exercise program personnel and
irector, less time, effort, and resources are required per
atient enrolled in a 2-month program, which translates to
cost-savings to train a given number of patients per year.
lternatively, the productivity of the exercise program
ould increase by training more patients per year with
imilar time, effort, and utilization of resources.
Other studies have found amore continuous increase in
OT and PWT during an exercise program.24,25 It should
e noted, however, that if the continuous increase in COT
nd PWT in previous studies were expressed relative to the
reater mileage walked and MET-minutes of exercise com-
leted during training, the trend of diminishing returns for
he outcome measures would be evident with each month
n the program.
Secondary outcome measures. Peak oxygen uptake
ncreased by 12% after the exercise program, which is
onsistent with most,9,15,25-27 but not all,14 previous stud-
es. Furthermore, performance during the 6-minute walk
est improved: we observed a 27% increase in pain-free
alking distance and an 8% increase in total walking dis-
ance. These findings support our previous observations of
26% to 44% increase in 6-minute walk pain-free distance
nd a 7% to 12% increase in total 6-minute walk distance
fter supervised exercise rehabilitation programs.9,14,15
The 24% increase in self-perceived walking speed from
he WIQ questionnaire after exercise rehabilitation in the
urrent study agrees with previous studies13,28 and is con-
istent with the increase in objectively measured walking
peed as evident by the increase in total walk distance
uring the 6-minute walk test. We also noted a 24% in-
rease in daily physical activity after exercise rehabilitation,
hich supports previous observations of 31% to 44% in-
reases9,13,15 and a 68% increase in the daily percentage of
ime spent in physical activity.28 Although there is a con-
istent increase in daily physical activity after exercise reha-
ilitation, there is high between-subject variability at any
iven time point of measurement.
Finally, we observed significant increases in calf blood
ow under resting, hyperemic, and maximal conditions as
ell as improvements in the ischemic window, supporting
he notion that exercise rehabilitation improves peripheral
irculation. However, an increase in calf blood flow is not a
onsistent finding after exercise rehabilitation.29
Other components of an exercise program to con-
ider in treating claudication. In addition to the pro-
ram length, an exercise program consists of other key
omponents that define the overall volume of exercise
erformed. These include intensity, duration, frequency,
b
o
t
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was completed (ie, under medical supervision or home-
based), and the claudication pain end point used during
Table IV. Regression estimates for linear trend of changes
(PWT) regressed on miles walked
Variables Intercept (95% CI)  sec/mile
COT
Months of exercise
1-2 32.96 (196.16 to 130.24)
3-4 45.48 (60.00 to 150.96)
5-6 1.47 (6.65 to 9.60)
PWT
Months of exercise
1-2 0.1253 (226.1905 to 225.9399)
3-4 16.6116 (152.0199 to 185.2430)
5-6 1.1184 (7.0578 to 4.8211)
CI, Confidence interval.
aP  .05.
Table V. Self-paced ambulation, self-perceived exercise pe
patients in the usual care control group (n  36) and exerc
Variablesa Baseline Month 2
Six-minute walk
Pain-free distance, m
Control group 154 (86) 184 (163)
Exercise group 165 (92) 180 (119)
Distance, m
Control group 393 (74) 404 (197)
Exercise group 368 (88) 404 (96)b
WIQ scores, %
Distance
Control group 34 (34) 32 (32)
Exercise group 34 (30) 45 (30)b
Speed
Control group 39 (27) 34 (41)
Exercise group 34 (24) 43 (24)b
Stair climbing
Control group 43 (29) 49 (34)
Exercise group 46 (29) 54 (31)
Daily physical activity, kcal/d
Control group 435 (208) 308 (288)
Exercise group 332 (207) 346 (205)
Calf blood flow, %/min
Rest
Control group 3.60 (1.17) 3.02 (1.65)
Exercise group 3.22 (1.09) 3.60 (1.29)b
PORH
Control group 10.42 (4.26) 8.71 (5.21)
Exercise group 8.50 (3.75) 9.64 (4.30)b
Maximal
Control group 15.77 (6.56) 15.53 (10.05)
Exercise group 12.02 (5.03) 12.89 (5.85)
ANOVA, Analysis of variance; GE, group effect; GxT, group by test inter
hyperemia; TE, test effect; WIQ, Walking Impairment Questionnaire.
aValues are means (standard deviation).
bChange from baseline (P  .05).
cChange from month 2 (P  .05).individual exercise sessions to define when walking should re discontinued (ie, walking to near-maximal, moderate, or
nset of pain). Although numerous studies have examined
he efficacy of exercise to treat claudication, including 15
laudication onset time (COT) and peak walking time
Slope (95% CI)  sec/mile r R2 P
13.07 (0.95 to 25.19)a 0.233 0.054 .035
0.18 (5.16 to 4.81) 0.0088 0.0001 .9434
.0097 (0.2886 to 0.2693) 0.0099 0.0001 .9447
.1754 (0.3548 to 33.9960)a 0.2202 0.0485 .0455
.3949 (6.5760 to 9.3657) 0.0430 0.0018 .7279
.0496 (0.1542 to 0.2534) 0.0690 0.0048 .6268
ance, physical activity, and calf blood flow measures of
roup (n  106)
Month 4 Month 6
ANOVA P for ITT
GE TE GxT
160 (95) 180 (149) NS .001 .001
186 (88) 210 (106)b,c
422 (128) 383 (116) NS .001 .001
402 (80)b 396 (92)b
43 (32) 38 (30) NS .001 NS
50 (33)b 47 (34)b
33 (27) 35 (29) NS NS .05
42 (27)b 42 (26)b
46 (38) 45 (37) NS NS NS
47 (31) 55 (31)
469 (470) 327 (233) NS .001 .001
413 (261)b,c 410 (272)b,c
3.73 (1.75)c 3.46 (1.32) NS .001 .01
3.84 (1.29)b 3.60 (1.06)b
10.42 (5.26) 9.53 (5.44) NS .01 .001
10.17 (3.86)b 10.86 (3.72)b,c
13.92 (6.39) 14.59 (7.36) NS .05 .001
13.98 (6.37)b 15.01 (6.73)b,c
; ITT, intent-to-treat; NS, not significant; PORH, postocclusive reactivein c
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Volume 55, Number 5 Gardner et al 1353more uncontrolled trials,33 relatively few answers can be
gleaned from the literature about how each component of
exercise influences the increases in COT and PWT.
Formulating an exercise prescription. The current
investigation focused on the changes in COT and PWT at
different lengths of time in an exercise program up to a
maximum of 6 months. Increases in COT and PWT occur
rapidly during the first 2 months of training and then begin
to plateau, especially when expressing the change scores
relative to mileage walked and MET-minutes completed
during training.
We previously reported that intensity of exercise train-
ing is not a significant factor for increasing COT and PWT,
provided that a similar volume of exercise is achieved,
because results from a higher-intensity, shorter-duration
program were not different than a lower-intensity, longer-
duration program.9 The lower-intensity program may be
the preferred method because it is well-tolerated, relatively
safe, and is similar to daily ambulation performed in the
community setting. In addition, we recently reported that
the efficacy of a monitored, home-based exercise program
with periodic feedback approached the level seen with
supervised exercise. Others have observed that nonambu-
latory exercise, such as arm and leg ergometry34-36 and
polestriding,37 are efficacious in increasing COT and PWT.
Thus, we believe that a more precise exercise prescrip-
tion is beginning to emerge for treating claudication, con-
sisting of training at relatively low intensity for longer
duration per exercise session and using walking or nonam-
bulatory exercise, or both, for at least 2 months. Further-
more, an exercise program that is monitored with periodic
feedback does not need to be limited to a hospital-based,
supervised setting; rather, this program can be exported to
a home-based setting.16
Study limitations. Although the results of this trial
support the efficacy of exercise rehabilitation for PAD
patients, several limitations exist: First, patients who partic-
ipated in this trial were volunteers and therefore may rep-
resent those who were more interested in exercise, who had
better access to transportation to the program, and who
had relatively better health than PAD patients who did not
volunteer.
Second, the study patients were predominantly men.
Consequently, the efficacy of exercise may not generalize to
women.
Third, the study patients were limited by intermittent
claudication, and thus the efficacy of exercise rehabilitation
to increase COT and PWTmay not be representative of the
response in patients with atypical claudication pain.
Fourth, the study design was limited to obtaining
change scores in outcome measures every 2 months. It is
possible that most of the improvement in COT and PWT
seen at the 2-month evaluation actually occurred sooner.
CONCLUSIONS
This prospective, randomized controlled trial demon-
strates that COT and PWT increase through the first 4
months of exercise rehabilitation, with minimal changeccurring during the final 2 months. However, relative to
he mileage walked during the program, increases in COT
nd PWT were only observed during the first 2 months of
he exercise program. We conclude that exercise-mediated
ains in COT and PWT occur rapidly within the first 2
onths of exercise rehabilitation and are maintained with
urther training. The clinical significance is that a relatively
hort 2-month exercise program may be preferred to a
onger program to treat claudication because adherence is
igher, costs associated with personnel and utilization of
acilities are lower per patient, and more patients can be
rained for a given amount of personnel time and resource
tilization.
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